天津市龙济男科哪个比较好治疗包皮武清区龙济男科,武清龙济上泌尿专科,武清龙济泌尿外科口碑好吗,天津龙济看男科好吗,龙济医院能使用农保嘛,天津武清龙济医院欧式微雕环切术,治疗包皮过长武清龙济医院信的过

President Donald Trump has reportedly asked the FDA to permit an untested herbal extract to be marketed as a dietary supplement and a potential cure for Covid-19, according to reporting by Axios.Housing and Urban Development Secretary Ben Carson and MyPillow founder and CEO Mike Lindell both support using oleander extract.Oleandrin is commonly used to treat heart conditions and asthma.Lindell, who is a vocal Trump supporter and personal friend, met with President Trump and Secretary Carson in July to tout the untested drug for use in coronavirus cases. President Trump vocalized support for the extract in the meeting, according to Axios.Lindell reportedly has a stake in Phoenix Biotechnology, the company that makes oleandrin.There is a small, non-peer-reviewed study that oleandrin inhibited coronavirus in test-tube experiments using monkey kidney cells.“I haven’t (pushed the FDA to approve it),” the president told reporters Monday morning when asked about oleandrin. When asked if it was something he would support, he responded, “Is it something that people are talking about very strongly? We’ll look at it, we’ll look at it. We’re looking at a lot of different things.” The president continued, “I’ve heard that name mentioned I’ll have to get back to you later.”In March, President Trump asked the FDA to authorize the emergency use of hydroxychloroquine to treat Covid-19. The FDA did, and then in June it revoked the authorization for its use because a large trial study found a “risk of heart rhythm problems” in patients treated with hydroxychloroquine. 1582

President Donald Trump and his Canadian and Mexican counterparts signed a replacement NAFTA deal on Friday during a ceremony on the sidelines of the G20 summit.The ceremonial signing does not mean the United-States-Mexico-Canada Agreement -- the USMCA, as it has been rebranded -- will now go into effect. The deal still needs to win congressional approval in Washington, where key members of both political parties have already expressed significant concerns."I don't expect to have much of a problem," Trump said during the ceremony.The signing ceremony in and of itself represented a political victory for Trump, who has been eager to mark the deal with a formal photo opportunity alongside Canadian Prime Minister Justin Trudeau and outgoing Mexican President Enrique Pe?a Nieto. It was not clear until just a day earlier that the ceremony would go through amid ongoing Canadian protests over US-imposed steel and aluminum tariffs.Top US officials were on hand for the signing ceremony, including Secretary of State Mike Pompeo, Treasury Secretary Steven Mnuchin, national security adviser John Bolton and the President's daughter Ivanka Trump and son-in-law Jared Kushner.The-CNN-Wire? & ? 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved. 1281

President Donald Trump has reportedly asked the FDA to permit an untested herbal extract to be marketed as a dietary supplement and a potential cure for Covid-19, according to reporting by Axios.Housing and Urban Development Secretary Ben Carson and MyPillow founder and CEO Mike Lindell both support using oleander extract.Oleandrin is commonly used to treat heart conditions and asthma.Lindell, who is a vocal Trump supporter and personal friend, met with President Trump and Secretary Carson in July to tout the untested drug for use in coronavirus cases. President Trump vocalized support for the extract in the meeting, according to Axios.Lindell reportedly has a stake in Phoenix Biotechnology, the company that makes oleandrin.There is a small, non-peer-reviewed study that oleandrin inhibited coronavirus in test-tube experiments using monkey kidney cells.“I haven’t (pushed the FDA to approve it),” the president told reporters Monday morning when asked about oleandrin. When asked if it was something he would support, he responded, “Is it something that people are talking about very strongly? We’ll look at it, we’ll look at it. We’re looking at a lot of different things.” The president continued, “I’ve heard that name mentioned I’ll have to get back to you later.”In March, President Trump asked the FDA to authorize the emergency use of hydroxychloroquine to treat Covid-19. The FDA did, and then in June it revoked the authorization for its use because a large trial study found a “risk of heart rhythm problems” in patients treated with hydroxychloroquine. 1582

President Donald Trump indicated this weekend to associates he is preparing to oust Veterans Affairs Secretary David Shulkin, a source familiar with the conversations confirmed to CNN.CNN's Jeff Zeleny has reported two officials said Shulkin remains the most vulnerable cabinet member.The announcement could happen as early as this week, the source said. However, until an announcement is made, no decision in the Trump White House is considered final.White House officials did not have any comment.Chris Ruddy, the CEO of Newsmax Media and a friend of Trump's, told ABC's "This Week" today that he talked with Trump this weekend and "he did say that he's expecting to make one or two major changes to his government very soon."Shulkin won unanimous confirmation by the Senate last year and had enjoyed bipartisan support and the backing of the President, who touted his legislative victories at VA. But the situation grew more tenuous in recent months with Shulkin telling reporters that Trump administration political appointees have been working to oust him over policy differences.The rift between Shulkin and those within the agency and at the White House became public in February after Shulkin was the subject of a damning inspector general report related to a trip that he took to Europe last summer.While his standing at the White House has diminished, he retains the support of key members of Congress and the nation's veterans service organizations.The Washington Post first reported about Trump telling associates he was planning on ousting Shulkin.When asked last week about Shulkin's status, a VA spokesperson said, "There are no personnel changes to announce at the Department of Veterans Affairs. President Trump has made clear that he expects the Department's sole focus to be on providing quality care to America's veterans who have sacrificed to keep this country free and safe."The spokesperson added, "President Trump tasked Secretary Shulkin with reforming the VA so it could better serve the men and women who sacrificed to protect our country. Many reforms have already been enacted, many more are still needed, but nothing will distract the President, the Secretary and the Department from finding the best ways to provide care and benefits to our country's heroes." 2299

President Donald Trump is ordering the expulsion of 60 Russian diplomats and the closure of the Russian consulate in Seattle, Washington, in the wake of the UK nerve agent attack, the White House announced Monday.The President is taking the action in response to the poisonings of a former Russian double agent and his daughter in England, the administration announced.Forty-eight of the diplomats work at the Russian embassy and a dozen at the United Nations in New York. They and their families will have seven days to leave the country."The United States takes this action in conjunction with our NATO allies and partners around the world in response to Russia's use of military grade chemical weapons on the soil of the United Kingdom, the latest in this ongoing pattern of destabilizing activities around the world," White House press secretary Sarah Sanders said.In December 2016, the US expelled 35 Russian diplomats in response to Russian meddling in the 2016 US presidential election.  1007